Targeting of polycombs to DNA in EMT
نویسندگان
چکیده
Epithelial cells may respond to instructive signals and profoundly change the expression profile in a transdifferentiation process known as Epithelialto-Mesenchymal Transition (EMT). Cells undergoing EMT progressively lose cell-cell adhesion and epithelial markers (primarily the E-cadherin) and rearrange apicalbasal polarity and cytoskeleton to acquire mesenchymal markers and migratory capacity [1]. The plasticity of EMT is further underlined by the ability of transitional cells to undergo a reverse Mesenchymal-to-Epithelial Transition (MET) in secondary sites and changed cellular environment. All these features confer to EMT-MET dynamics a key role in developmental and physiological processes (such as organogenesis, tissue homeostasis, wound healing, regeneration, stem cell plasticity) as well as in fibrosis, tumor growth and, particularly, tumor metastasis, for which it represents a rate-limiting step [2]. EMT-MET balance implies a strict regulation of transcription. With respect to transcriptional factors, repressors of the Snail, ZEB and Twist families, and in particular the member Snail1 (Snail), act as “masters”, sufficient to trigger and guide the reprogramming. Furthermore, recent evidence demonstrated that epigenetic mechanisms are mandatory in EMT-MET dynamics and correlated Enhancer of Zeste Homolog 2 (EZH2), the Polycomb Repressive Complex 2 (PRC2) catalytic member, to Snail-mediated repression [3]. Conceivably, a master factor has the capacity to organize a molecular platform that profoundly impacts the chromatin state by i) recruiting chromatin modifiers to specific genes (thus triggering or impeding target genes transcriptional competency) and/or ii) allowing the enrolment of other transcriptional factors and/or coregulators. Molecular mechanisms linking master factors and the main writers of chromatin repressive marks are still largely unknown. In addition, molecular mechanisms by which Polycomb proteins interact with genomic targets are still debated in mammals (differently from what is found in Drosophila, in which DNA Polycomb Response Elements (PREs) are involved) where Polycomb members could be recruited to each gene through interactions with sequencespecific DNA-binding factors [4]. Notably, lncRNA HOTAIR was found to bind to PRC2, targeting its H3K27-mediated methylation to discrete regions of the genome [5]. While the PRC2-RNA interactions have been questioned as promiscuous in in vitro studies [6], in vivo HOTAIR is an excellent predictor of metastasis being able to induce a genome-wide PRC2 retargeting in epithelial tumors. This evidence still leaves different possible mechanisms open (e.g. how is HOTAIR/EZH2 complex recruited? The lncRNA directly promotes targeting or it modulates function?). In Battistelli et al. [7], different working hypotheses of how EZH2 gets to its genomic targets have been reconciled: provided evidence demonstrates as a DNA binding transcriptional factor can recruit to specific sites a general chromatin modifier by means of a long noncoding RNA, that is required to bridge the two proteins in a functional complex. This, in turn, allows the coordinated regulation of a broad repertoire of genes in reprogramming phenomena. At the same time, a new paradigm of function for a lncRNA has been highlighted: a lncRNA conveys to specific sites a general chromatin modifier through a DNA-binding transcriptional factor. Battistelli and Coworkers demonstrated, specifically in hepatocyte cells, that the EMT master repressor Snail directs EZH2 activity to specific genes through the enrolment of the lncRNA HOTAIR (Figure 1). Functional in vivo analysis highlighted that the Snail repressive activity in EMT depends on the formation of this Snail/ HOTAIR/EZH2 complex. Moreover, the HOTAIREditorial
منابع مشابه
Epithelial to mesenchymal transition concept in Cancer: Review article
Owing to this fact that most of the mortalities in cancers are as a result of metastasis, study on the involved pathways in metastasis including Epithelial to mesenchymal transition (EMT) would be so critical and important. Up to date, several extensive studies have been carried out to determine the correlation between EMT and cancer and their results have shown that the EMT plays pivotal role ...
متن کاملMesenchymal Stem Cells Trigger Epithelial to Mesenchymal Transition in the HT-29 Colorectal Cancer Cell Line
Background and Objective: Mesenchymal stem cells (MSCs) promote metastasis in colorectal cancer; however, the mechanism underlying this process is not fully understood. Epithelial to mesenchymal transition (EMT) is a key step in tumor acquisition of metastatic phenotype. We aimed to investigate the effect of MSCs on the expression of EMT markers, as well as cancer stem cell markers in HT-29 col...
متن کاملAXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers.
Epithelial to mesenchymal transition (EMT) is associated with a wide range of changes in cancer cells, including stemness, chemo- and radio-resistance, and metastasis. The mechanistic role of upstream mediators of EMT has not yet been well characterized. Recently, we showed that non-small cell lung cancers (NSCLC) that have undergone EMT overexpress AXL, a receptor tyrosine kinase. AXL is also ...
متن کاملThe Effect of Plant-derived Compounds in Targeting Cancer Stem Cells
Background Cancer stem cells (CSCs) are a small subpopulation of cancer cells with self-renewal and differentiation ability. Furthermore, CSCs are resistant to chemoradiotherapy due to their high level of detoxifying enzymes, strong DNA repair abilities, and high drug efflux capacity. Objective Therefore, CSCs are supposed to account for cancer initiation, progression, metastasis, recurrence, ...
متن کاملEMT related lncrnas’ as novel biomarkers in glioblastoma: a review article
Glioma is the most common type of brain tumor and according to the 2016 WHO classification, based on invasion level, it is divided into four categories. The most severe and invasive type is grade IV glioma or glioblastoma (GBM), which has a very poor prognosis and a survival rate of only 15 months. However, the molecular pathway of invasion in malignant glioma tumors has not yet been clearly el...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 8 شماره
صفحات -
تاریخ انتشار 2017